Al-Aqar Healthcare REIT (XKLS:5116) ROCE %: 7.89% (As of Mar. 2026)


XKLS:5116 Al-Aqar Healthcare REIT XKLS:5116
70 GF Score
Price RM1.17
GF Value RM1.31
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Al-Aqar Healthcare REIT ROCE %?

Al-Aqar Healthcare REIT XKLS:5116 70 ROCE % is 7.89% as of Mar. 2026. GuruFocus rates XKLS:5116 with a GF Score™ of 70/100 and a GF Value™ of RM1.31 (Modestly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Al-Aqar Healthcare REIT's annualized ROCE % for the quarter that ended in Mar. 2026 was 7.89%.


Al-Aqar Healthcare REIT  (XKLS:5116) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Al-Aqar Healthcare REIT ROCE % Related Terms


Al-Aqar Healthcare REIT ROCE % Historical Data

* Premium members only.

The historical data trend for Al-Aqar Healthcare REIT's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Al-Aqar Healthcare REIT ROCE % Chart

Al-Aqar Healthcare REIT Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.33 4.94 5.39 5.45 5.93

Al-Aqar Healthcare REIT Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.56 6.05 6.84 5.53 7.89
XKLS:5116
70GF Score
Al-Aqar Healthcare REIT XKLS:5116
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Al-Aqar Healthcare REIT ROCE % Calculation

Al-Aqar Healthcare REIT's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=93.736/( ( (1835.937 - 115.618) + (2087.611 - 645.834) )/ 2 )
=93.736/( (1720.319+1441.777)/ 2 )
=93.736/1581.048
=5.93 %

Al-Aqar Healthcare REIT's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=113.792/( ( (2087.611 - 645.834) + (2092.493 - 648.179) )/ 2 )
=113.792/( ( 1441.777 + 1444.314 )/ 2 )
=113.792/1443.0455
=7.89 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 7.89% mean?
Al-Aqar Healthcare REIT (XKLS:5116) has a ROCE % of 7.89% as of Mar. 2026.
Is Al-Aqar Healthcare REIT's ROCE % too high?
Al-Aqar Healthcare REIT's current ROCE % is 7.89%. The REITs industry median ROCE % is 5.19. Al-Aqar Healthcare REIT's value of 7.89% is 52.2% above this industry median. Overall, Al-Aqar Healthcare REIT has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Al-Aqar Healthcare REIT's ROCE % compare to WELL and VTR?
Al-Aqar Healthcare REIT's ROCE % of 7.89% can be compared against companies in the REITs industry. The industry median ROCE % is 5.19. Al-Aqar Healthcare REIT's value of 7.89% is 52.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a REITs company?
The median ROCE % among REITs companies is 5.19, based on 756 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Al-Aqar Healthcare REIT's current ROCE % of 7.89% is 52.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the REITs industry, the median ROCE % is 5.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Al-Aqar Healthcare REIT's current ROCE % is 7.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Al-Aqar Healthcare REIT stock overvalued right now?
Based on GuruFocus' analysis, Al-Aqar Healthcare REIT (XKLS:5116) is currently considered Modestly Undervalued. The stock's GF Value™ is RM1.31, compared to a current price of RM1.17 — trading 10.7% below its estimated fair value. The current ROCE % is 7.89% and 52.2% above the REITs industry median of 5.19. Al-Aqar Healthcare REIT's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Al-Aqar Healthcare REIT (XKLS:5116), the current ROCE % is 7.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Al-Aqar Healthcare REIT (XKLS:5116) Overvalued in 2026?

Based on GuruFocus' analysis, Al-Aqar Healthcare REIT stock appears to be undervalued. The current stock price of RM1.17 is trading 10.7% below its estimated GF Value™ of RM1.31. GuruFocus considers Al-Aqar Healthcare REIT to be Modestly Undervalued.

Key valuation signals for XKLS:5116:

  • ROCE %: 7.89%
  • GF Value™: RM1.31 vs. price of RM1.17 (10.7% below fair value)
  • GF Score™: 70/100 with 5 warning signs
  • Industry Position: 52.2% above the REITs median

No single metric tells the full story. See the XKLS:5116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Al-Aqar Healthcare REIT Business Description

Industry Real EstateREITs
Address Unit 1-19-02, Level 19, Block 1, V SQUARE, Jalan Utara, Petaling Jaya, SGR, MYS, 46200
Al-Aqar Healthcare REIT is engaged in investing in Syariah-compliant properties with the primary objective of providing unitholders with distribution and potential for the sustainable long-term growth of such distribution and capital appreciation. The company operates in Malaysia and Australia. The Malaysian geographic segment generates the maximum revenue for the company.
70GF Score

Get the complete analysis for XKLS:5116

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM1.17
Price
RM1.31
GF Value